Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25622825 | 0.81 | ACHE (0.36) | POLBL3MBTL1PKMMAPTMEN1 | |
| SCHEMBL23947579 | 0.74 | CYP1A1 (0.40) | POLBL3MBTL1GAAHSP90AA1HSP90AB1 | |
| SCHEMBL23947203 | 0.71 | CYP1A2 (0.44) | POLBL3MBTL1GAAHSP90AA1HSP90AB1 | |
| SCHEMBL23947106 | 0.69 | NSD2 (0.42) | L3MBTL1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL30254383 | 0.67 | MAPT (0.53) | POLBL3MBTL1TRPV4MAPTGAA | |
| SCHEMBL16047636 | 0.67 | MAPT (0.53) | POLBL3MBTL1TRPV4MAPTGAA | |
| SCHEMBL23946703 | 0.66 | NSD2 (0.45) | POLBL3MBTL1MAPTMEN1LMNA | |
| SCHEMBL585492 | 0.63 | TRPV4 (0.50) | POLBL3MBTL1TRPV4MAPTMEN1 | |
| SCHEMBL29359707 | 0.63 | TRPV4 (0.50) | POLBL3MBTL1TRPV4MAPTMEN1 | |
| SCHEMBL264507 | 0.63 | ERN1 (0.40) | POLBL3MBTL1TRPV4MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174544-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174544-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY2, CYBA, AHR | POLB 2421/4885L3MBTL1 110/4885TRPV4 2762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.